Laura Harris
Adolescent Medicine · Atlanta, GANPI 1295721348
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations.
Across 107 payments — averaging $19.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tris Pharma Inc$329
- Cranial Technologies, Inc$307
- Sanofi-aventis U.S. LLC$192
- Pfizer$191
- Supernus Pharmaceuticals, Inc.$129
- Kaleo, Inc.$126
- plus $817 from 21 others
What the payments were for
- Food & beverage$2,01396%
- Gifts$482%
- Other$291%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tris Pharma Inc | 18 | $329 |
| Cranial Technologies, Inc | 16 | $307 |
| Sanofi-aventis U.S. LLC | 9 | $192 |
| Pfizer | 10 | $191 |
| Supernus Pharmaceuticals, Inc. | 6 | $129 |
| Kaleo, Inc. | 8 | $126 |
| Corium, LLC | 5 | $124 |
| GSK | 6 | $103 |
| Abbott | 2 | $86 |
| Sanofi Pasteur Inc. | 4 | $68 |
| Merck | 4 | $54 |
| AstraZeneca | 2 | $48 |
| Welch Allyn | 1 | $48 |
| Seqirus USA Inc | 2 | $36 |
| Shire North American Group Inc | 2 | $30 |
| Baxter Healthcare | 1 | $29 |
| Boston Scientific | 1 | $24 |
| LNHC, Inc | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Boehringer Ingelheim | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
| Adlon Therapeutics L.p. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Novartis | 1 | $16 |
| Phadia US Inc. | 1 | $13 |
| Neos Therapeutics, LP | 1 | $12 |
How this compares
$2,089 in reported general payments places this provider in the 85th percentile of 78 adolescent medicine providers in Georgia.
Other adolescent medicine in Atlanta
- Allison KoenigAtlanta$3K
- Elizabeth GriffithAtlanta$3K
- Raseefa AnwarAtlanta$2K
- Samantha HillAtlanta$606
- Richard WeilAtlanta$473
- Zenia FlemingAtlanta$298
- Anuradha ShethLawrenceville$33K
- Young KangDuluth$24K
- Alan AlvaradoValdosta$3K
- Ronald MagatDawsonville$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.